Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230432 | SCV001402911 | pathogenic | not provided | 2023-10-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu434Alafs*40) in the MERTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MERTK are known to be pathogenic (PMID: 24265693, 29659094). This variant is present in population databases (rs776644374, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with rod-cone dystrophy (PMID: 29659094). ClinVar contains an entry for this variant (Variation ID: 957448). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001230432 | SCV001447553 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376500 | SCV001573671 | likely pathogenic | Retinitis pigmentosa 38 | 2021-04-08 | criteria provided, single submitter | research | The MERTK c.1301_1302del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely Pathogenic. |
Faculty of Health Sciences, |
RCV001257898 | SCV001434666 | pathogenic | Autosomal recessive retinitis pigmentosa | 2018-05-23 | no assertion criteria provided | literature only |